The journal Acta Virologica will move to gold open access publisher Frontiers in April, as part of an agreement signed by the Institute of Virology from the Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS).
The agreement is Frontiers’ first publishing partnership in Slovakia and marks an important step forward for open access in the field of virology.
Commenting on the agreement, Dr. Silvia Pastorekova, director general of BMC SAS, said: "We are excited to partner with Frontiers and bring Acta Virologica to a wider audience. Frontiers' commitment to open access and innovative publishing solutions help us achieve our mission of advancing virology research and improving global health.”
Acta Virologica is an international journal focusing mainly on molecular and cellular virology, publishing fundamental research related to human, animal and plant viruses. Areas of interest range from the morphology of viruses to vaccines and antiviral drugs.
Established in 1957, the journal was previously published under a hybrid model by AEPress. Acta Virologica will open for submissions on Frontiers’ fully open access platform in spring 2023.
Robyn Mugridge, head of publishing partnerships at Frontiers, commented: “We look forward to partnering with BMC SAS for the transition of Acta Virologica to a fully open access model, and we are pleased to celebrate Frontiers’ first publishing partner in Slovakia.”
Acta Virologica joins Frontiers' growing community of publishing partners in the biomedical sciences. In late 2022, both the Journal of Pharmacy & Pharmaceutical Sciences and the Society for Experimental Biology and Medicine announced new partnerships with Frontiers, adding to the deal with the British Journal of Biomedical Science.
Keep up-to-date with publishing news: sign up here for InPubWeekly, our free weekly e-newsletter.
